Antibiotic Resistance Current Trends and Future Directions

Abstract

Background: Antibiotic resistance is a universally aggravated health problem stemming from the abuse of antibiotics resulting in antibiotic resistant bacteria. Due to multidrug resistant infections arising almost in all health facilities, it becomes very difficult for the health care facilities to treat most common infections causing prolonged hospitalization, higher health costs, and high mortality rate.

Objectives: In order to assess how effective the new antibiotic regimen is going to be in decreasing the disparity of resistant bacterial infections in the hospitalised patient population.

Study design : A cross-sectional study 

Palace and duration of study. Department of pulmonology Gkmc swabi form Jan 2024 to March 2024

Methods:  involving 150 hospitalized patients, who were divided into two groups: one, which was given standard antibiotics and the other given the new antibiotic. Information was gathered on infection rates and the time for recovery. As for the effectiveness of the new antibiotic, the prevention both of infection rates, as well as the p-values to establish the significance of the results obtained were also calculated. Mean ± SD was used to ascertain intersatisfaction treatment variability.

Results: The group given the new antibiotic had a significant decrease in infection rates as they recovered within an average of 7.3 days (SD±1.5) while the groups given standard antibiotic recovered within 9.6 days (SD±2.1). Signifying a probability level of 0.02 the data shows a statistical difference between the two groups and supports the use of the new antibiotic in reducing resistant infections.

Conclusions: The new antibiotic was more effective in preventing infection incidences and time to recovery than the conventional antibiotics. These results may have implications for the utility of this antibiotic in expanding treatment strategies targeting infections caused by antibiotic-resistant organisms.